奧萊利 ORLY 深 滬
等待開盤 09-06 09:30:00 美东时间
104.84
-0.200
-0.19%
華盛通- 最 高105.315
- 今 開105.315
- 成交量 420.27万股
- 最 低 103.595
- 昨 收 105.04
- 總市值 889.04亿
- 52周最高 105.315
- 市盈率 靜 38.68
- 換手率 0.50%
- 52周最低 73.3337
- 委 比 -93.28%
- 總股本 8.48亿
- 歷史最高 105.315
- 量 比 1.29
- 振 幅 1.64%
- 歷史最低 3.75
- 每 手 1
- 風險率 7.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多花旗8月零售客流报告：RH(RH.US)等增长延续可期，BJ批发俱乐部(BJ.US)同比考验较大
花旗发布研报，对所评级的零售商8月客流量数据进行点评。该行指出，Placer商店客流量数据显示，8月份花旗所评级的公司平均增长了2.0%。这一增长率较7月份的...
09-05 17:23
美国消费降级潮扩散：中产阶层的信心也“塌方”了？
①尽管烈日当空，但对美国中产阶级而言，这个夏天的信心却在持续降温； ②密歇根大学上周公布的一项备受关注的调查显示，美国消费者信心指数在6月和7月持续攀升后，8月骤降了近6%。
09-01 15:30
Price Over Earnings Overview: O'Reilly Automotive
In the current market session, O'Reilly Automotive Inc. (NASDAQ:ORLY) stock pri...
08-28 23:00
Iterum Therapeutics Launches New Antibiotic ORLYNVAH
Iterum Therapeutics ( ($ITRM) ) has issued an update. On August 20, 2025, Iteru...
08-20 20:45
Iterum Therapeutics Announces U.S. Commercial Launch Of ORLYNVAH Oral Tablets
Iterum Therapeutics plc (NASDAQ:ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today
08-20 20:02
美国企业承担了多少关税成本？
本文来自格隆汇专栏：中金研究；作者：刘刚 郝悦宁 自今年年初特朗普上任后，各种针对国家（地区）和行业的关税政策层出不穷，目前美国根据每月关税收入计算的实际有效...
08-20 07:49
Advance Auto Parts lowers FY25 profit guidance on borrowing costs
Advance Auto Parts (NYSE:AAP) lowered its outlook for FY25 to reflect slowing sales momentum and increased borrowing costs, driving shares down by as much as 18% on Thursday. Despite an improvement in...
08-14 22:43
Evercore ISI Group Maintains Outperform on O'Reilly Automotive, Raises Price Target to $110
Evercore ISI Group analyst Greg Melich maintains O'Reilly Automotive (NASDAQ:ORLY) with a Outperform and raises the price target from $108 to $110.
08-12 20:57
Is O'Reilly Automotive Gaining or Losing Market Support?
O'Reilly Automotive's (NYSE:ORLY) short percent of float has fallen 13.64% sinc...
08-12 03:00
Iterum Therapeutics Non-GAAP EPS of -$0.13
Iterum Therapeutics press release (NASDAQ:ITRM): Q2 Non-GAAP EPS of -$0.13. Cash and cash equivalents were $13.0 million as of June 30, 2025. Based on Iterum’s current operating plan, Iterum expects t...
08-05 19:16
